AtriCure Inc ATRC

US Health Care

$37.76 ▼ -5.95% ($-2.39)

⬇️ Below Yest. Low

Open $39.39

Prev Close $40.15

Day Range $37.44 – $39.41

52W Range $25.36 – $43.18

Market Cap $1.92B

P/E (TTM) 187.86

Beta 1.24

EPS (TTM) $0.22

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2005-08-05
Shares Out.	50,870,000
Website	atricure.com ↗
Phone	13026587581
Employees	1,350
Revenue	$153.6M
Gross Profit	$118.6M
Net Income	$9.0M
Free Cash Flow	$53.1M
Total Assets	$676.6M
Total Liabilities	$160.2M
Equity	$516.4M

About AtriCure Inc

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

AtriCure Inc is a publicly traded company under the ticker symbol ATRC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.